The findings highlight the potential benefits of newer biologics targeting IL-12, IL-23, and IL-17 while also raising ...

Department of Medicine, University of Toronto, Women's College Hospital, and co-authors have found biologics targeting ...

Korea: A recent retrospective cohort study published in the Journal of the American Academy of Dermatology explored the link ...

Biologics targeting interleukin-12, -23, and -17 were associated with a lower rate of serious infections among older adults ...

Medically reviewed by Anita C. Chandrasekaran, MD Many people associate psoriatic arthritis (PsA) with itchy, scaly skin and ...

Tremfya is also approved to treat patients with plaque psoriasis, active psoriatic arthritis and ulcerative colitis and is ...

Psoriatic arthritis can affect any joint in the body ... Your doctor will work to rule these out when making a diagnosis. There are many treatment options available for PsA.

Affiliate content. Discover the best products for arthritis in hands, including supplements, creams, and tools designed to ...

Dr. Reddy's inks collaboration deal with Bio-Thera to develop and commercialize proposed biosimilar candidates of J&J's Stelara and Simponi in Southeast Asia.

Steqeyma is indicated for the treatment of plaque psoriasis and psoriatic arthritis in adult and pediatric patients, as well ...

IL-23, or IL-17 reduced serious infections, while tofacitinib increased infection risk, according to one study.